Bloomberg Intelligence: Live Nation Lawsuit, Micron Earnings, and Starbucks Restructuring

Live Nation Antitrust Lawsuit

• 🏛️ The FTC and seven states have sued Live Nation Entertainment and Ticketmaster for failing to prevent the use of automated ticketing bots and large-scale resale operations.
• 🤖 This lawsuit is not a surprise, as the FTC recently sued a smaller entity over the same law, the Better Ticketing Online Sales Act (Bots Act), and President Trump ordered better enforcement.
• 💰 Live Nation and Ticketmaster allegedly profit from the resale market by taking fees on primary tickets and then additional fees when tickets are resold on Ticketmaster's resale arm, effectively "double dipping."
• ⚖️ The Department of Justice has also sued Live Nation for anti-competitive activity, suggesting the only remedy is to force them to sell Ticketmaster, as behavioral conditions have been violated twice.
• 🤝 The FTC lawsuit is likely to end in a settlement due to astronomical penalties, while the DOJ suit is expected to go to trial in March, with a jury verdict anticipated.

Micron Earnings and AI Demand

• 📉 Micron's shares fell after its first-quarter forecast disappointed investors, despite revenue and profit exceeding estimates.
• 🚀 The company's stock has nearly doubled year-to-date, driven by AI-fueled optimism and strong demand for high bandwidth memory (HBM).
• 📊 HBM is crucial for AI, and its increasing demand constrains supply for traditional products like smartphones and PCs, leading to potential pricing increases.
• 📈 The memory chip industry, historically cyclical, is experiencing an extended upcycle, potentially lasting 12 quarters or more, due to structural tailwinds from AI.
• 🌐 The competitive landscape for HBM is dominated by SK Hynix, Micron, and Samsung, who account for the majority of DRAM and NAND demand.

Pharmaceutical and Health News

• 💊 Pfizer is acquiring the obesity startup Metsera for $4.9 billion to compete in the massive obesity drug market, despite its own weight-loss medications not performing as well as rivals'.
• 🧪 Metsera's drugs are early-stage, with a later-stage drug similar to GLP-1s and an earlier-stage analog drug, both targeting the pathway between food intake and satiety.
• ⚠️ The Trump administration warned pregnant women against using Tylenol (acetaminophen) due to a potential link to ADHD and autism, though scientific evidence is not widely accepted, with sibling studies showing no increased risk.
• 📉 The Tylenol warning is unlikely to have a material impact on companies like Kenvue, as it represents a small portion of sales and physicians already recommend limited use during pregnancy.

Consumer Tech and Telecom Updates

• 💍 Oura Health, maker of the Oura Ring, is raising $875 million at an $11 billion valuation, surpassing competitors like Peloton and iRobot combined.
• 💡 Oura's success is attributed to its strong brand, functionality, and first-mover advantage, though a potential Apple ring could disrupt the market.
• 📈 T-Mobile is promoting COO Shini Gopalan to CEO, replacing Mike Sivert, as the company competes in wireless and home internet markets.
• 🌐 T-Mobile has excelled in subscriber growth and customer engagement, with international data and texting perks being a significant draw; future growth is expected in broadband.

Media and Foodservice News

• 🎤 Jimmy Kimmel returned to late-night television, addressing political controversies and advocating for free speech, though his show generates significantly less ad revenue than in previous years.
• 📉 Late-night shows are generally losing money due to high programming budgets and declining linear TV viewership, making them less of a financial driver for networks like ABC.
• ☕ Starbucks announced a $1 billion restructuring plan, closing stores and eliminating 900 jobs, as new CEO Brian Nickel focuses on improving operations and marketing to drive sales growth.
• ⏳ The turnaround for Starbucks is expected to take time, with fiscal year 2026 anticipated as a strong bounce-back year, though investors may lose patience if same-store sales do not improve in early fiscal 2026.